chr3_-_129325175
|
2.396
|
NM_015103
|
PLXND1
|
plexin D1
|
chr21_+_46825001
|
2.344
|
NM_130445
|
COL18A1
|
collagen, type XVIII, alpha 1
|
chr17_-_76921205
|
2.140
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
chr19_-_18717467
|
2.105
|
|
CRLF1
|
cytokine receptor-like factor 1
|
chr7_-_50861114
|
2.077
|
NM_001001555
|
GRB10
|
growth factor receptor-bound protein 10
|
chr17_-_76921076
|
1.969
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
chr15_+_63334753
|
1.954
|
NM_000366
NM_001018004
NM_001018005
NM_001018006
NM_001018007
NM_001018020
|
TPM1
|
tropomyosin 1 (alpha)
|
chr19_-_18717631
|
1.883
|
NM_004750
|
CRLF1
|
cytokine receptor-like factor 1
|
chr20_-_50384861
|
1.851
|
|
ATP9A
|
ATPase, class II, type 9A
|
chr18_-_25757351
|
1.803
|
NM_001792
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
chr1_-_85930610
|
1.796
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
chr8_+_136469557
|
1.731
|
NM_006558
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
chr15_+_63335086
|
1.659
|
|
TPM1
|
tropomyosin 1 (alpha)
|
chr2_+_9346909
|
1.618
|
|
ASAP2
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
|
chr7_-_50860665
|
1.573
|
|
GRB10
|
growth factor receptor-bound protein 10
|
chr20_-_50384899
|
1.555
|
NM_006045
|
ATP9A
|
ATPase, class II, type 9A
|
chr14_+_105941061
|
1.543
|
NM_001312
|
CRIP2
|
cysteine-rich protein 2
|
chr17_-_76921453
|
1.526
|
NM_003255
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
chr3_-_185542807
|
1.501
|
NM_001007225
NM_006548
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
chr19_-_18717577
|
1.491
|
|
CRLF1
|
cytokine receptor-like factor 1
|
chr2_-_161349874
|
1.443
|
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1
|
chr21_+_46825291
|
1.431
|
|
|
|
chr8_+_136470108
|
1.418
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
chr14_-_30396811
|
1.368
|
NM_002742
|
PRKD1
|
protein kinase D1
|
chr10_-_15413054
|
1.340
|
NM_001010924
|
FAM171A1
|
family with sequence similarity 171, member A1
|
chr2_+_9346876
|
1.331
|
NM_001135191
NM_003887
|
ASAP2
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
|
chr1_-_85930733
|
1.308
|
NM_012137
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
chr2_+_236402685
|
1.258
|
NM_001037131
NM_001244888
NM_014914
|
AGAP1
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
|
chr7_+_128470462
|
1.250
|
NM_001127487
NM_001458
|
FLNC
|
filamin C, gamma
|
chr3_-_38691118
|
1.246
|
NM_000335
NM_001099404
NM_001099405
NM_198056
NM_001160160
NM_001160161
|
SCN5A
|
sodium channel, voltage-gated, type V, alpha subunit
|
chr5_-_176900653
|
1.195
|
NM_004395
|
DBN1
|
drebrin 1
|
chr1_-_22263676
|
1.189
|
NM_005529
|
HSPG2
|
heparan sulfate proteoglycan 2
|
chr11_-_86666211
|
1.187
|
NM_012193
|
FZD4
|
frizzled family receptor 4
|
chr11_-_65640199
|
1.178
|
NM_016938
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2
|
chr6_-_52441815
|
1.171
|
NM_012288
|
TRAM2
|
translocation associated membrane protein 2
|
chr9_+_103235634
|
1.146
|
|
TMEFF1
|
transmembrane protein with EGF-like and two follistatin-like domains 1
|
chr5_+_34656482
|
1.145
|
|
RAI14
|
retinoic acid induced 14
|
chr11_-_78128765
|
1.138
|
|
GAB2
|
GRB2-associated binding protein 2
|
chr7_-_131241321
|
1.126
|
NM_001018111
NM_005397
|
PODXL
|
podocalyxin-like
|
chr5_+_34656595
|
1.120
|
NM_001145520
|
RAI14
|
retinoic acid induced 14
|
chr5_+_34656367
|
1.105
|
NM_001145522
NM_015577
|
RAI14
|
retinoic acid induced 14
|
chr19_-_1567875
|
1.097
|
NM_001174118
NM_203304
|
MEX3D
|
mex-3 homolog D (C. elegans)
|
chr5_-_176900591
|
1.086
|
|
DBN1
|
drebrin 1
|
chr1_-_95392501
|
1.075
|
NM_001839
|
CNN3
|
calponin 3, acidic
|
chr2_+_102314162
|
1.073
|
NM_001242560
NM_004834
NM_145686
NM_001242559
NM_145687
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
chr14_+_105781180
|
1.070
|
|
PACS2
|
phosphofurin acidic cluster sorting protein 2
|
chr12_+_3068442
|
1.053
|
NM_003213
NM_201441
NM_201443
|
TEAD4
|
TEA domain family member 4
|
chr19_+_33685489
|
1.048
|
NM_002333
|
LRP3
|
low density lipoprotein receptor-related protein 3
|
chr11_+_46402333
|
1.047
|
NM_001012334
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
chr11_-_2160199
|
1.037
|
NM_000612
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
chr3_-_185542744
|
1.035
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
chr5_-_126366068
|
1.033
|
|
MARCH3
|
membrane-associated ring finger (C3HC4) 3
|
chr7_-_150946031
|
1.027
|
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
chr6_-_52441714
|
1.026
|
|
TRAM2
|
translocation associated membrane protein 2
|
chr9_+_103235489
|
1.020
|
NM_003692
|
TMEFF1
|
transmembrane protein with EGF-like and two follistatin-like domains 1
|
chr2_+_177053306
|
1.013
|
NM_024501
|
HOXD1
|
homeobox D1
|
chr3_-_52567708
|
1.009
|
NM_001134231
|
NT5DC2
|
5'-nucleotidase domain containing 2
|
chr18_-_5543967
|
1.005
|
NM_012307
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
chr10_+_104404195
|
1.005
|
NM_030912
|
TRIM8
|
tripartite motif containing 8
|
chr11_-_75236866
|
0.999
|
|
GDPD5
|
glycerophosphodiester phosphodiesterase domain containing 5
|
chr2_-_99347430
|
0.987
|
|
MGAT4A
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A
|
chr9_+_138371627
|
0.984
|
NM_014811
|
PPP1R26
|
protein phosphatase 1, regulatory subunit 26
|
chr6_-_170124065
|
0.982
|
|
PHF10
|
PHD finger protein 10
|
chr2_+_97481977
|
0.980
|
NM_017623
NM_199078
|
CNNM3
|
cyclin M3
|
chr1_-_95392449
|
0.978
|
|
CNN3
|
calponin 3, acidic
|
chr3_-_149688638
|
0.976
|
NM_002628
NM_053024
|
PFN2
|
profilin 2
|
chr1_+_25071967
|
0.972
|
|
CLIC4
|
chloride intracellular channel 4
|
chr22_+_38201113
|
0.964
|
NM_005318
|
H1F0
|
H1 histone family, member 0
|
chr2_-_39664430
|
0.956
|
|
MAP4K3
|
mitogen-activated protein kinase kinase kinase kinase 3
|
chr5_-_179498598
|
0.949
|
|
RNF130
|
ring finger protein 130
|
chr13_+_98795410
|
0.932
|
NM_001001715
NM_005766
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)
|
chr6_+_148663953
|
0.930
|
|
SASH1
|
SAM and SH3 domain containing 1
|
chr9_+_96338671
|
0.906
|
NM_005392
|
PHF2
|
PHD finger protein 2
|
chr21_-_44846927
|
0.900
|
NM_173354
|
SIK1
|
salt-inducible kinase 1
|
chr14_+_100259445
|
0.898
|
NM_001008707
NM_004434
|
EML1
|
echinoderm microtubule associated protein like 1
|
chr3_-_124605840
|
0.897
|
|
ITGB5
|
integrin, beta 5
|
chr2_-_16847070
|
0.892
|
NM_030797
|
FAM49A
|
family with sequence similarity 49, member A
|
chr10_-_735522
|
0.890
|
NM_014974
|
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila)
|
chr2_-_39664291
|
0.877
|
|
MAP4K3
|
mitogen-activated protein kinase kinase kinase kinase 3
|
chr9_+_137533643
|
0.875
|
NM_000093
|
COL5A1
|
collagen, type V, alpha 1
|
chr13_+_98795468
|
0.873
|
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)
|
chrX_+_117861523
|
0.871
|
NM_001560
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
chr11_-_2906960
|
0.863
|
NM_000076
NM_001122630
NM_001122631
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
chr13_+_98795710
|
0.852
|
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)
|
chr22_+_23412364
|
0.851
|
NM_002073
|
GNAZ
|
guanine nucleotide binding protein (G protein), alpha z polypeptide
|
chr6_-_170124086
|
0.851
|
NM_018288
NM_133325
|
PHF10
|
PHD finger protein 10
|
chr1_+_39547088
|
0.845
|
NM_012090
|
MACF1
|
microtubule-actin crosslinking factor 1
|
chr2_-_127864505
|
0.844
|
NM_004305
NM_139343
NM_139344
NM_139345
NM_139346
NM_139347
NM_139348
NM_139349
NM_139350
NM_139351
|
BIN1
|
bridging integrator 1
|
chr1_+_25071906
|
0.842
|
|
CLIC4
|
chloride intracellular channel 4
|
chr11_-_63536112
|
0.837
|
NM_001144936
|
C11orf95
|
chromosome 11 open reading frame 95
|
chr8_+_97657581
|
0.833
|
|
PGCP
|
plasma glutamate carboxypeptidase
|
chr22_-_29075708
|
0.833
|
NM_001145418
|
TTC28
|
tetratricopeptide repeat domain 28
|
chr6_+_71998508
|
0.833
|
|
OGFRL1
|
opioid growth factor receptor-like 1
|
chr19_+_3094528
|
0.829
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
chr1_+_2160133
|
0.827
|
NM_003036
|
SKI
|
v-ski sarcoma viral oncogene homolog (avian)
|
chr6_+_71998476
|
0.821
|
NM_024576
|
OGFRL1
|
opioid growth factor receptor-like 1
|
chr19_+_3094266
|
0.818
|
NM_002067
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
chr2_-_220436010
|
0.813
|
|
OBSL1
|
obscurin-like 1
|
chr8_+_97657592
|
0.799
|
|
PGCP
|
plasma glutamate carboxypeptidase
|
chr8_+_1711869
|
0.797
|
NM_018941
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
|
chr6_+_163835783
|
0.781
|
|
QKI
|
QKI, KH domain containing, RNA binding
|
chr5_-_111093251
|
0.770
|
NM_001142479
NM_001142480
NM_001142478
|
C5orf13
|
chromosome 5 open reading frame 13
|
chr14_+_59104736
|
0.768
|
NM_001079520
NM_016651
|
DACT1
|
dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis)
|
chr3_-_52567809
|
0.762
|
|
NT5DC2
|
5'-nucleotidase domain containing 2
|
chr4_+_41362750
|
0.760
|
NM_001112717
NM_001112718
NM_014988
|
LIMCH1
|
LIM and calponin homology domains 1
|
chr8_+_97506141
|
0.759
|
|
SDC2
|
syndecan 2
|
chr14_+_105780903
|
0.757
|
|
PACS2
|
phosphofurin acidic cluster sorting protein 2
|
chr7_+_94139331
|
0.756
|
|
CASD1
|
CAS1 domain containing 1
|
chr8_-_12990731
|
0.753
|
NM_006094
|
DLC1
|
deleted in liver cancer 1
|
chr20_-_60942300
|
0.752
|
NM_005560
|
LAMA5
|
laminin, alpha 5
|
chr8_+_97506071
|
0.747
|
|
SDC2
|
syndecan 2
|
chr3_+_187871473
|
0.738
|
NM_001167672
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
chr6_+_148663728
|
0.734
|
NM_015278
|
SASH1
|
SAM and SH3 domain containing 1
|
chr8_-_67525426
|
0.732
|
NM_001080416
NM_001144755
|
MYBL1
LOC645895
|
v-myb myeloblastosis viral oncogene homolog (avian)-like 1
uncharacterized LOC645895
|
chr10_-_62703822
|
0.728
|
NM_001242359
NM_014836
|
RHOBTB1
|
Rho-related BTB domain containing 1
|
chr4_+_4861371
|
0.727
|
NM_002448
|
MSX1
|
msh homeobox 1
|
chr10_+_123922940
|
0.726
|
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
chr10_-_15210610
|
0.724
|
NM_004808
|
NMT2
|
N-myristoyltransferase 2
|
chr2_+_85811530
|
0.721
|
NM_006634
|
VAMP5
|
vesicle-associated membrane protein 5 (myobrevin)
|
chr4_-_186456580
|
0.715
|
NM_001114107
NM_014476
|
PDLIM3
|
PDZ and LIM domain 3
|
chr7_-_150945731
|
0.715
|
NM_001003801
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
chr6_-_7910716
|
0.715
|
NM_030810
|
TXNDC5
|
thioredoxin domain containing 5 (endoplasmic reticulum)
|
chr3_-_124606129
|
0.709
|
NM_002213
|
ITGB5
|
integrin, beta 5
|
chr12_-_124457099
|
0.709
|
NM_025140
|
CCDC92
|
coiled-coil domain containing 92
|
chr7_+_98246595
|
0.704
|
NM_002523
|
NPTX2
|
neuronal pentraxin II
|
chr10_-_17659365
|
0.692
|
NM_014241
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A
|
chr1_+_25071759
|
0.691
|
NM_013943
|
CLIC4
|
chloride intracellular channel 4
|
chr13_+_48807492
|
0.688
|
|
ITM2B
|
integral membrane protein 2B
|
chrX_-_34675366
|
0.683
|
NM_031442
|
TMEM47
|
transmembrane protein 47
|
chr8_+_97506020
|
0.681
|
|
SDC2
|
syndecan 2
|
chr4_-_80994183
|
0.680
|
|
|
|
chr2_-_218843541
|
0.679
|
|
TNS1
|
tensin 1
|
chr17_-_56032494
|
0.677
|
|
CUEDC1
|
CUE domain containing 1
|
chr2_-_175869910
|
0.675
|
NM_001822
NM_001025201
|
CHN1
|
chimerin (chimaerin) 1
|
chr4_+_3768295
|
0.674
|
NM_000683
|
ADRA2C
|
adrenergic, alpha-2C-, receptor
|
chr8_+_97657452
|
0.673
|
NM_016134
|
PGCP
|
plasma glutamate carboxypeptidase
|
chr11_+_832965
|
0.672
|
|
CD151
|
CD151 molecule (Raph blood group)
|
chr7_-_19157262
|
0.672
|
NM_000474
|
TWIST1
|
twist homolog 1 (Drosophila)
|
chr17_-_78194085
|
0.672
|
NM_000199
|
SGSH
|
N-sulfoglucosamine sulfohydrolase
|
chr12_-_106641675
|
0.668
|
NM_006825
|
CKAP4
|
cytoskeleton-associated protein 4
|
chr8_+_97506478
|
0.666
|
|
SDC2
|
syndecan 2
|
chr7_-_559479
|
0.662
|
NM_002607
NM_033023
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
chr3_+_39851028
|
0.661
|
NM_015460
|
MYRIP
|
myosin VIIA and Rab interacting protein
|
chr12_-_15942350
|
0.657
|
NM_004447
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
chr12_-_15942116
|
0.655
|
|
EPS8
|
epidermal growth factor receptor pathway substrate 8
|
chr5_+_72921980
|
0.655
|
NM_001080479
NM_001177693
|
RGNEF
|
190 kDa guanine nucleotide exchange factor
|
chr6_+_71998514
|
0.654
|
|
OGFRL1
|
opioid growth factor receptor-like 1
|
chr11_-_75236418
|
0.651
|
NM_030792
|
GDPD5
|
glycerophosphodiester phosphodiesterase domain containing 5
|
chr19_+_50016500
|
0.646
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
chr14_-_105262078
|
0.644
|
NM_001014431
NM_001014432
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
chr11_+_833007
|
0.640
|
|
CD151
|
CD151 molecule (Raph blood group)
|
chr5_-_111093792
|
0.638
|
NM_001142477
NM_001142476
|
C5orf13
|
chromosome 5 open reading frame 13
|
chr16_-_4166185
|
0.632
|
NM_001116
|
ADCY9
|
adenylate cyclase 9
|
chr22_+_38201232
|
0.632
|
|
H1F0
|
H1 histone family, member 0
|
chr16_+_58497993
|
0.631
|
NM_001130487
|
NDRG4
|
NDRG family member 4
|
chr1_-_94702916
|
0.629
|
|
ARHGAP29
|
Rho GTPase activating protein 29
|
chr14_-_105262015
|
0.629
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
chr3_+_61547179
|
0.629
|
NM_002841
|
PTPRG
|
protein tyrosine phosphatase, receptor type, G
|
chr2_-_1748240
|
0.629
|
|
PXDN
|
peroxidasin homolog (Drosophila)
|
chr8_+_61591239
|
0.628
|
NM_017780
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
chr3_+_37903643
|
0.627
|
NM_001008392
NM_005808
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like
|
chr2_-_113191106
|
0.623
|
NM_001164463
NM_005054
|
RGPD8
RGPD5
|
RANBP2-like and GRIP domain containing 8
RANBP2-like and GRIP domain containing 5
|
chr15_-_26108236
|
0.623
|
NM_024490
|
ATP10A
|
ATPase, class V, type 10A
|
chr2_-_183902747
|
0.622
|
|
NCKAP1
|
NCK-associated protein 1
|
chr2_-_73339911
|
0.619
|
|
RAB11FIP5
|
RAB11 family interacting protein 5 (class I)
|
chr22_+_37956404
|
0.618
|
NM_152243
|
CDC42EP1
|
CDC42 effector protein (Rho GTPase binding) 1
|
chr13_+_48807307
|
0.614
|
|
ITM2B
|
integral membrane protein 2B
|
chr6_-_7910278
|
0.612
|
NM_001145549
|
TXNDC5
|
thioredoxin domain containing 5 (endoplasmic reticulum)
|
chr4_-_7941092
|
0.612
|
NM_001134647
NM_198595
|
AFAP1
|
actin filament associated protein 1
|
chr20_+_30193083
|
0.601
|
NM_002165
NM_181353
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
chr1_-_235812994
|
0.598
|
NM_001098722
|
GNG4
|
guanine nucleotide binding protein (G protein), gamma 4
|
chr1_+_78444922
|
0.598
|
|
DNAJB4
|
DnaJ (Hsp40) homolog, subfamily B, member 4
|
chr16_-_52580805
|
0.597
|
NM_001080430
|
TOX3
|
TOX high mobility group box family member 3
|
chr11_-_33890931
|
0.594
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
chr12_+_70759974
|
0.593
|
NM_014505
|
KCNMB4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4
|
chr22_-_47134130
|
0.591
|
NM_022766
|
CERK
|
ceramide kinase
|
chr7_-_559030
|
0.590
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
chr1_+_182992694
|
0.588
|
|
|
|
chr2_-_73340058
|
0.583
|
|
RAB11FIP5
|
RAB11 family interacting protein 5 (class I)
|
chr6_+_163835668
|
0.578
|
NM_006775
NM_206853
NM_206854
NM_206855
|
QKI
|
QKI, KH domain containing, RNA binding
|
chr15_+_83776323
|
0.574
|
NM_001144903
NM_023003
|
TM6SF1
|
transmembrane 6 superfamily member 1
|
chr7_-_95064213
|
0.573
|
NM_000305
NM_001018161
|
PON2
|
paraoxonase 2
|
chr1_+_99127146
|
0.569
|
NM_015976
NM_152238
|
SNX7
|
sorting nexin 7
|
chr9_-_74979625
|
0.554
|
|
ZFAND5
|
zinc finger, AN1-type domain 5
|
chr14_-_65438794
|
0.551
|
NM_198686
|
RAB15
|
RAB15, member RAS onocogene family
|
chr17_-_56065596
|
0.550
|
NM_007146
|
VEZF1
|
vascular endothelial zinc finger 1
|
chr5_-_57755787
|
0.550
|
NM_001252226
NM_006622
|
PLK2
|
polo-like kinase 2
|
chr16_+_58497628
|
0.550
|
|
NDRG4
|
NDRG family member 4
|
chr2_-_39664129
|
0.547
|
NM_003618
|
MAP4K3
|
mitogen-activated protein kinase kinase kinase kinase 3
|
chr17_-_74707066
|
0.546
|
|
MXRA7
|
matrix-remodelling associated 7
|
chr17_-_56065474
|
0.544
|
|
VEZF1
|
vascular endothelial zinc finger 1
|
chr17_-_80009649
|
0.544
|
NM_002917
|
RFNG
|
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
|
chr1_+_23037329
|
0.543
|
NM_004442
NM_017449
|
EPHB2
|
EPH receptor B2
|
chr20_+_11871364
|
0.542
|
NM_181443
|
BTBD3
|
BTB (POZ) domain containing 3
|
chr5_+_76011780
|
0.540
|
NM_001992
|
F2R
|
coagulation factor II (thrombin) receptor
|
chr9_-_16870719
|
0.537
|
NM_017637
|
BNC2
|
basonuclin 2
|
chr5_-_179498995
|
0.533
|
NM_018434
|
RNF130
|
ring finger protein 130
|
chr3_-_128207366
|
0.531
|
NM_001145661
|
GATA2
|
GATA binding protein 2
|
chr1_-_33168356
|
0.529
|
NM_001161708
NM_030786
|
SYNC
|
syncoilin, intermediate filament protein
|
chr11_-_119234628
|
0.529
|
|
USP2
|
ubiquitin specific peptidase 2
|